AnaptysBio Inc (ANAB) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Add to Alerts ADD TO LIST

$53.08

$1.82 (-3.32%)

Last update: 03:07 AM EST

Day's range

$52.56

$57.63

Recent Analyst Forecasts and Stock Ratings

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date	Details
01/07/2026	UBS	Michael Yee	$70.00	$43.91	59.42%
12/17/2025	Barclays	Etzer Darout	$55.00	$45.03	22.14%
11/10/2025	Wedbush	David Nierengarten	$50.00	$33.26	50.33%
11/10/2025	Truist Financial	Joon Lee	$36.00	$34.28	5.03%
10/15/2025	Wedbush	David Nierengarten	$70.00	$31.85	119.78%
05/06/2025	Guggenheim	Yatin Suneja	$54.00	$20.12	168.39%
02/03/2025	Wolfe Research	Andy Chen	$25.00	$16.66	50.06%
12/11/2024	H.C. Wainwright	Emily Bodnar	$19.00	$15.51	22.5%
11/06/2024	H.C. Wainwright	Emily Bodnar	$52.00	$19.38	168.32%
11/06/2024	Leerink Partners	David Risinger	$45.00	$19.38	132.2%
10/21/2024	Guggenheim	Yatin Suneja	$90.00	$34.98	157.29%
10/15/2024	Piper Sandler	Yasmeen Rahimi	$80.00	$34.74	130.28%
10/03/2024	New Street	David Risinger	$35.00	$35.22	-0.62%
08/15/2024	Truist Financial	Joon Lee	$30.00	$34.65	-13.42%
04/16/2024	Leerink Partners	David Risinger	$47.00	$21.27	120.97%

AnaptysBio Inc FAQ's

AnaptysBio Inc has been rated by research analysts at UBS, Guggenheim, Barclays, Stifel Nicolaus, Wedbush, Truist Financial in the past 90 days.